FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Xaqua 5mg tablets (Renascience Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 20 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Roma Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Xaqua 5mg tablets (Renascience Pharma Ltd) 20 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Roma Pharmaceuticals Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrocolloid dressing semi-permeable sterile with adhesive border 14cm x 14cm square VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (A A H Pharmaceuticals Ltd) 5 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Adalimumab 80mg/0.8ml solution for injection pre-filled syringes VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Adalimumab 80mg/0.8ml solution for injection pre-filled syringes 1 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Humira 80mg/0.8ml solution for injection pre-filled syringes (AbbVie Ltd) 1 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Humira 80mg/0.8ml solution for injection pre-filled syringes (AbbVie Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Yuflyma 80mg/0.8ml solution for injection pre-filled syringes (Celltrion Healthcare UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Yuflyma 80mg/0.8ml solution for injection pre-filled syringes (Celltrion Healthcare UK Ltd) 1 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Vapor-permeable adhesive film dressing 10cm x 14cm VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Cutifilm dressing 10cm x 14cm (Smith & Nephew Healthcare Ltd) 50 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
365 Film dressing 10cm x 14cm (365 Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Vapour-permeable adhesive film dressing 10cm x 14cm 50 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Premierfilm I.V. dressing 10cm x 14cm (Shermond) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levothyroxine sodium 100micrograms/5ml oral solution sugar free (Wockhardt UK Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
365 Film dressing 10cm x 14cm (365 Healthcare Ltd) 50 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
365 Film dressing 10cm x 14cm (365 Healthcare Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Vapour-permeable adhesive film dressing 10cm x 14cm 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Vapour-permeable adhesive film dressing 10cm x 14cm 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cutifilm dressing 10cm x 14cm (Smith & Nephew Healthcare Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cutifilm dressing 10cm x 14cm (Smith & Nephew Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Premierfilm I.V. dressing 10cm x 14cm (Shermond) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Premierfilm I.V. dressing 10cm x 14cm (Shermond) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levothyroxine sodium 100micrograms/5ml oral solution sugar free (Wockhardt UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 75micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 50micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 100micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 75micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 25micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 25micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 50micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 100micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phytomenadione 10mg tablets 50 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phyto-K 10mg tablets (TriOn Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phyto-K 10mg tablets (TriOn Pharma Ltd) 50 tablet 5 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Galpharm Rapid Ibuprofen lysine 342mg tablets (Galpharm International Ltd) 16 tablet 2 x 8 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Galpharm Rapid Ibuprofen lysine 342mg tablets (Galpharm International Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1mg/10ml solution for injection pre-filled syringes VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Martindale Pharmaceuticals Ltd) 28 capsule 4 x 7 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Martindale Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Fresubin Jucy drink starter pack VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lancets sterile single use type A 0.46mm/26gauge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Dexcel-Pharma Ltd) 28 capsule 4 x 7 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Dexcel-Pharma Ltd) 28 capsule 4 x 7 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
FarlaCONTACT dressing 7.5cm x 10cm (Farla Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
FarlaCONTACT dressing 20cm x 30cm (Farla Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fresubin Jucy drink starter pack (Fresenius Kabi Ltd) 1200 ml 1 x (2 x 200ml + 4 x 200ml) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
On Call lancets 0.46mm/26gauge (Connect2Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Dexcel-Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
FarlaCONTACT dressing 20cm x 30cm (Farla Medical Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
On Call lancets 0.46mm/26gauge (Connect2Pharma Ltd) 100 lancet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Dexcel-Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
FarlaCONTACT dressing 5cm x 7.5cm (Farla Medical Ltd) 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
MPD Ultra Thin lancets 0.46mm/26gauge (Medical Plastic Devices Inc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
FarlaCONTACT dressing 7.5cm x 10cm (Farla Medical Ltd) 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
FarlaCONTACT dressing 7.5cm x 10cm (Farla Medical Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
MPD Ultra Thin lancets 0.46mm/26gauge (Medical Plastic Devices Inc) 200 lancet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
FarlaCONTACT dressing 20cm x 30cm (Farla Medical Ltd) 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
FarlaCONTACT dressing 5cm x 7.5cm (Farla Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lancets sterile single use type A 0.46mm/26gauge 200 lancet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
MPD Ultra Thin lancets 0.46mm/26gauge (Medical Plastic Devices Inc) 100 lancet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fresubin Jucy drink starter pack (Fresenius Kabi Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Fresubin Jucy drink starter pack 1200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
FarlaCONTACT dressing 5cm x 7.5cm (Farla Medical Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lancets sterile single use type A 0.46mm/26gauge 100 lancet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iohexol 755mg/ml (Iodine 350mg/ml) solution for injection 100ml bottles VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iohexol 647mg/ml (Iodine 300mg/ml) solution for injection 100ml bottles VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Omnipaque 350 solution for injection 100ml bottles (GE Healthcare Biosciences) 10 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iohexol 755mg/ml (Iodine 350mg/ml) solution for injection 100ml bottles 10 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Omnipaque 300 solution for injection 100ml bottles (GE Healthcare Biosciences) 10 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Teva UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Omnipaque 300 solution for injection 100ml bottles (GE Healthcare Biosciences) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iohexol 647mg/ml (Iodine 300mg/ml) solution for injection 100ml bottles 6 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iohexol 647mg/ml (Iodine 300mg/ml) solution for injection 100ml bottles 10 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets (A A H Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Omnipaque 300 solution for injection 100ml bottles (GE Healthcare Ltd) 6 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Omnipaque 350 solution for injection 100ml bottles (GE Healthcare Biosciences) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dipyridamole 200mg modified-release / Aspirin 25mg capsules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Asasantin Retard capsules (PI) (Waymade Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Asasantin Retard capsules (PI) (Waymade Ltd) 60 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Asasantin Retard capsules (Mawdsley-Brooks & Company Ltd) 60 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Molita 200mg/25mg modified-release capsules (Dr Reddy's Laboratories (UK) Ltd) 60 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Dipyridamole 200mg modified-release / Aspirin 25mg capsules 60 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Dipyridamole 200mg modified-release / Aspirin 25mg capsules 100 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Molita capsules (Dr Reddy's Laboratories (UK) Ltd) 100 capsule 2 x 50 capsules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Asasantin Retard capsules (Boehringer Ingelheim Ltd) 60 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) 60 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Molita capsules (Dr Reddy's Laboratories (UK) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Asasantin Retard capsules (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Asasantin Retard capsules (PI) (Dowelhurst Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Asasantin Retard capsules (PI) (Dowelhurst Ltd) 60 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Asasantin Retard capsules (Boehringer Ingelheim Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous foam VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mexiletine 50mg capsules 84 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 5 of 86 Next End

This concept is not in any reference sets

Back to Start